210 related articles for article (PubMed ID: 38397136)
1. Dysregulation of the Skin-Liver Axis in Prurigo Nodularis: An Integrated Genomic, Transcriptomic, and Population-Based Analysis.
Marani M; Madan V; Le TK; Deng J; Lee KK; Ma EZ; Kwatra SG
Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397136
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in dysregulation of the renin-angiotensin-aldosterone system in patients with prurigo nodularis.
Sutaria N; Marani M; Choi J; Roh YS; Parthasarathy V; Deng J; Bordeaux ZA; Taylor MT; Lee KK; Pritchard T; Alajmi A; Adawi W; Semenov YR; Alphonse MP; Kwatra SG
J Dermatol Sci; 2022 Feb; 105(2):130-136. PubMed ID: 35151532
[TBL] [Abstract][Full Text] [Related]
3. Single-cell profiling of prurigo nodularis demonstrates immune-stromal crosstalk driving profibrotic responses and reversal with nemolizumab.
Ma F; Gharaee-Kermani M; Tsoi LC; Plazyo O; Chaskar P; Harms P; Patrick MT; Xing X; Hile G; Piketty C; Lazzari A; Van Delm W; Maverakis E; Nakamura M; Modlin RL; Kahlenberg JM; Billi AC; Julia V; Krishnaswamy JK; Gudjonsson JE
J Allergy Clin Immunol; 2024 Jan; 153(1):146-160. PubMed ID: 37506977
[TBL] [Abstract][Full Text] [Related]
4. RNA sequencing reveals the transcriptome profile of the atopic prurigo nodularis with severe itching.
Shao Y; Zhu Y; Xiao Z; Shen Y; Dai B; Tang H; Wang D
Exp Dermatol; 2023 Jan; 32(1):30-40. PubMed ID: 36134503
[TBL] [Abstract][Full Text] [Related]
5. A critical review of dupilumab for adult patients with prurigo nodularis.
Biazus Soares G; Yosipovitch G
Expert Rev Clin Immunol; 2024 Mar; 20(3):249-254. PubMed ID: 37811660
[TBL] [Abstract][Full Text] [Related]
6. Dupilumab Treatment for Prurigo Nodularis and Pruritis.
Tanis R; Ferenczi K; Payette M
J Drugs Dermatol; 2019 Sep; 18(9):940-942. PubMed ID: 31524352
[TBL] [Abstract][Full Text] [Related]
7. [Psychosomatic aspects of prurigo nodularis].
Schneider G; Hockmann J; Stumpf A
Hautarzt; 2014 Aug; 65(8):704-8. PubMed ID: 25113329
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab.
Tsoi LC; Hacini-Rachinel F; Fogel P; Rousseau F; Xing X; Patrick MT; Billi AC; Berthier CC; Kahlenberg JM; Lazzari A; Wiegmann H; Ständer S; Piketty C; Julia V; Krishnaswamy JK; Gudjonsson JE
J Allergy Clin Immunol; 2022 Apr; 149(4):1329-1339. PubMed ID: 34857395
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis.
Williams KA; Roh YS; Brown I; Sutaria N; Bakhshi P; Choi J; Gabriel S; Chavda R; Kwatra SG
Expert Rev Clin Pharmacol; 2021 Jan; 14(1):67-77. PubMed ID: 33191806
[No Abstract] [Full Text] [Related]
10. Validation of Psychometric Properties of the Itch Numeric Rating Scale for Pruritus Associated With Prurigo Nodularis: A Secondary Analysis of a Randomized Clinical Trial.
Kimel M; Zeidler C; Kwon P; Revicki D; Ständer S
JAMA Dermatol; 2020 Dec; 156(12):1354-1358. PubMed ID: 32936233
[TBL] [Abstract][Full Text] [Related]
11. Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.
Husein-ElAhmed H; Steinhoff M
J Dermatolog Treat; 2022 May; 33(3):1547-1553. PubMed ID: 33200955
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of pruritus in prurigo nodularis.
Shao Y; Wang D; Zhu Y; Xiao Z; Jin T; Peng L; Shen Y; Tang H
Front Immunol; 2023; 14():1301817. PubMed ID: 38077377
[TBL] [Abstract][Full Text] [Related]
13. Ethnic differences and comorbidities of 909 prurigo nodularis patients.
Boozalis E; Tang O; Patel S; Semenov YR; Pereira MP; Stander S; Kang S; Kwatra SG
J Am Acad Dermatol; 2018 Oct; 79(4):714-719.e3. PubMed ID: 29733939
[TBL] [Abstract][Full Text] [Related]
14. The impact of prurigo nodularis on quality of life: a systematic review and meta-analysis.
Janmohamed SR; Gwillim EC; Yousaf M; Patel KR; Silverberg JI
Arch Dermatol Res; 2021 Oct; 313(8):669-677. PubMed ID: 33108524
[TBL] [Abstract][Full Text] [Related]
15. Association between Prurigo Nodularis and Etiologies of Peripheral Neuropathy: Suggesting a Role for Neural Dysregulation in Pathogenesis.
Hughes JM; Woo TE; Belzberg M; Khanna R; Williams KA; Kwatra MM; Hassan S; Kwatra SG
Medicines (Basel); 2020 Jan; 7(1):. PubMed ID: 31936197
[No Abstract] [Full Text] [Related]
16. Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis.
Kwatra SG; Rodriguez D; Dias-Barbosa C; Budhiarso I; Fofana F; Vernon M; Gabriel S; Piketty C; Puelles J
Dermatol Ther (Heidelb); 2023 Oct; 13(10):2403-2416. PubMed ID: 37615836
[TBL] [Abstract][Full Text] [Related]
17. Single-Cell RNA Sequencing Reveals Dysregulated POSTN+WNT5A+ Fibroblast Subclusters in Prurigo Nodularis.
Patel JR; Joel MZ; Lee KK; Kambala A; Cornman H; Oladipo O; Taylor M; Imo BU; Ma EZ; Manjunath J; Kollhoff AL; Deng J; Parthasarathy V; Cravero K; Marani M; Szeto M; Zhao R; Sankararaman S; Li R; Henry S; Pritchard T; Rebecca V; Kwatra MM; Ho WJ; Dong X; Kang S; Kwatra SG
J Invest Dermatol; 2024 Jan; ():. PubMed ID: 38246584
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of peripheral blood laboratory testing in the diagnostic workup of prurigo nodularis: A multicenter cohort study.
Cornman HL; Deng J; Kambala A; Parthasarathy V; Reddy SV; Kwatra SG
JAAD Int; 2023 Dec; 13():74-82. PubMed ID: 37711338
[TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix and dermal nerve growth factor dysregulation in prurigo nodularis compared to atopic dermatitis.
Deng J; Parthasarathy V; Marani M; Bordeaux Z; Lee K; Trinh C; Cornman HL; Kambala A; Pritchard T; Chen S; Sutaria N; Oladipo OO; Kwatra MM; Alphonse MP; Kwatra SG
Front Med (Lausanne); 2022; 9():1022889. PubMed ID: 36619628
[TBL] [Abstract][Full Text] [Related]
20. INDIVIDUAL ARTICLE: Management of Prurigo Nodularis.
Elmariah SB; Tao L; Valdes-Rodriguez R; Laquer V
J Drugs Dermatol; 2023 Dec; 22(12):SF365502s15-SF365502s22. PubMed ID: 38051855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
